Diversification across four businesses: Healthcare, Nutraceuticals, Consumer Products and Other
First written in FY2016-Q2. 28 of 29 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 181 subsidiaries and 26 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues its healthcare-centered, diversified business structure based on 4 reportable segments. The number of subsidiaries is stated as 181 and the number of affiliated companies as 26. - FY2024RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 173 subsidiaries and 28 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related (note), consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues its healthcare-centered, diversified business structure based on 4 reportable segments. It is stated to comprise 173 subsidiaries and 28 affiliated companies. - FY2024-H1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group (the Company and its affiliated companies) during the cumulative interim consolidated accounting period. There were also no changes among the major affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2024-Q1RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the three-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2023RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 167 subsidiaries and 28 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues its healthcare-centered diversified structure based on 4 reportable segments. - FY2023-Q3RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure based on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2023-Q2RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2023-Q1RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the three-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2022RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 167 subsidiaries and 28 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues to operate a healthcare-centered, diversified business structure based on 4 reportable segments. - FY2022-Q3RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2022-Q1RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the three-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2021RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 169 subsidiaries and 30 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues to operate a healthcare-centered, diversified business structure based on 4 reportable segments. - FY2020RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 168 subsidiaries and 25 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues to operate a healthcare-centered, diversified business structure based on 4 reportable segments. - FY2020-Q3RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2020-Q1RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the three-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2019RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 167 subsidiaries and 27 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related (note), consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues its healthcare-centered, diversified business structure based on 4 reportable segments. It is stated to comprise 167 subsidiaries and 27 affiliated companies. - FY2019-Q3RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the nine-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2019-Q1RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the three-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments: healthcare-related, nutraceuticals-related, consumer-related and other. - FY2018RestatedAnnual report
「The Group, comprising the Company and its affiliated companies, consists of the Company, 162 subsidiaries and 26 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues its healthcare-centered business structure based on 4 reportable segments. The Group is now stated to comprise 162 subsidiaries and 26 affiliated companies. - FY2018-Q3RestatedAnnual report
「During the 9-month period ended the third quarter, there were no material changes in the businesses conducted by the Group, comprising the Company and its affiliated companies. Changes involving major affiliated companies were generally as follows.」
States that there were no material changes to the business structure centered on 4 reportable segments, while Ricoh Medical and ビステラ社 were included in the scope of consolidation. - FY2018-Q2RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2018-Q1RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the three-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2017RestatedAnnual report
「The Group consists of the Company, 152 subsidiaries and 30 affiliated companies. It places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas, including warehousing and transportation, liquid crystal and spectroscopy, and chemicals.」
The Group continues to operate a healthcare-centered, diversified business structure based on 4 reportable segments. - FY2017-Q3RestatedAnnual report
「There were no material changes during the cumulative third quarter in the nature of the businesses operated by our Group, comprising the Company and its affiliates.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2017-Q2RestatedAnnual report
「There have been no material changes in the nature of the businesses operated by our group, comprising the Company and its affiliated companies, during the six-month period ended this quarter. There have also been no changes among our principal affiliated companies.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2017-Q1RestatedAnnual report
「There were no material changes during the cumulative first quarter in the nature of the businesses operated by our Group, comprising the Company and its affiliates.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2016RestatedAnnual report
「The Group places healthcare at the core of its business and conducts healthcare-related, nutraceuticals-related, consumer-related and other business activities in Japan and overseas.」
The annual report also explicitly presents the business structure based on 4 reportable segments. - FY2016-Q3RestatedAnnual report
「There were no material changes during the cumulative third quarter in the nature of the businesses operated by our Group, comprising the Company and its affiliates.」
States that there have been no material changes to the business structure centered on 4 reportable segments. - FY2016-Q2First statedAnnual report
「Healthcare-related business, nutraceuticals-related business, consumer-related business and other businesses」
The business is structured around 4 reportable segments.